SYMBIOTEC vs EQUITASBNK: Stock Comparison
Head-to-head financial and trading comparison between Symbiotec Pharmalab Limited (SYMBIOTEC) and Equitas Small Finance Bank Limited (EQUITASBNK) in the Cross-Sector Peers sector.
SYMBIOTEC
NSE: SYMBIOTECEQUITASBNK
NSE: EQUITASBNKKey Metrics Comparison Table
| Metric | SYMBIOTEC | EQUITASBNK | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,087.50 | ₹66.02 | — |
| 1-Year Price Return | -0.93% | +3.29% | EQUITASBNK (4.22% higher) |
| 52-Week High | ₹1,198.00 | ₹83.07 | — |
| 52-Week Low | ₹1,003.35 | ₹63.92 | — |
| 30-Day Annualized Volatility | 53.35% | 27.7% | EQUITASBNK (Steadier) |
| 30-Day Average Daily Volume | 2,798,957 | 1,696,172 | SYMBIOTEC (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between SYMBIOTEC and EQUITASBNK, which stock gave better returns over the last year?
EQUITASBNK has outperformed SYMBIOTEC over the past 12 months with a gain of 3.29% compared to -0.93%.
Which stock is less volatile: SYMBIOTEC or EQUITASBNK?
EQUITASBNK demonstrated lower price volatility (27.7% annualized) compared to SYMBIOTEC (53.35%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of SYMBIOTEC vs EQUITASBNK?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are SYMBIOTEC and EQUITASBNK direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.